METHOD OF TREATING CANCER IN A MAMMAL, INCLUDING A HUMAN, USING METHIONINE AND ASPARAGINE DEPLETION Russian patent published in 2020 - IPC A61K38/46 A61K35/18 A61K38/51 A61P35/00 

Abstract RU 2733389 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to use of a kit for treating cancer in a mammal. That is ensured by using asparaginase and methioninase for at least one sequential administration, where methioninase is introduced before asparaginase. Group of inventions also relates to use of a pharmaceutical composition comprising asparaginase for treating cancer in a mammal, to which methioninase is administered, as well as to a method of treating cancer in a mammal in need thereof.

EFFECT: group of inventions provides higher efficacy of the present treatment by a combination of two agents administered according to a certain schedule, in comparison with introduction of each of these agents separately, or with introduction of the same agents according to another scheme.

25 cl, 4 dwg, 9 tbl, 9 ex

Similar patents RU2733389C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION CONTAINING ERYTHROCYTES IN WHICH AN ENZYME DEPENDENT ON PYRIDOXALPHOSPHATE IS ENCLOSED, AND COFACTOR THEREOF 2015
  • Godfren Yann
  • Borzho Vanessa
  • Ge Faben
  • Kortez Toma
RU2697086C2
PHARMACEUTICAL COMPOSITION COMPRISING ERYTHROCYTES CONTAINING ENZYME DEPENDENT ON PYRIDOXALPHOSPHATE AND COFACTOR THEREOF 2015
  • Godfrin, Yann
  • Bourgeaux, Vanessa
  • Gay, Fabien
  • Cortese, Thomas
RU2744659C2
ARGININE DEIMINASE ENCAPSULATED IN ERYTHROCYTES, AND THEIR USE IN TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY 2018
  • Dufour, Emmanuelle
  • Blanc, Manuel
  • Meyzaud, Aurelien
RU2773220C2
METHOD FOR STABILIZING SUSPENSIONS OF RED BLOOD CELLS ENCAPSULATING ACTIVE INGREDIENT AND SUSPENSIONS OBTAINED 2014
  • Godfren Yann
  • Borzho Vanessa
  • Belli Zherom
RU2668688C2
MEDICAMENT FOR TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) 2013
  • Godfrin Yann
RU2667639C2
METHOD OF PRODUCING A METHIONINE-GAMMA-LYASE ENZYME, AN ANTITUMOR DRUG FDF MGL BASED ON SAID ENZYME AND USE OF SAID AGENT FOR TUMOR GROWTH INHIBITION (VERSIONS) 2018
  • Manukhov Ilya Vladimirovich
  • Bazhenov Sergej Vladimirovich
  • Gnuchikh Evgenij Yurevich
  • Pokrovskij Vadim Sergeevich
  • Davydov Denis Zhanovich
  • Kotova Vera Yurevna
  • Bulushova Natalya Vladimirovna
  • Zavilgelskij Gennadij Borisovich
RU2733440C2
CHIMERIC ENZYME MGL-S3 - METHIONINE-GAMMA-LYASE FUSED WITH S3 DOMAIN OF VGF PROTEIN FROM VACCINIA VIRUS, METHOD FOR PRODUCING MGL-S3 AND ANTICANCER PREPARATION BASED ON THIS ENZYME 2022
  • Bondarev Nikolai Antonovich
  • Bazhenov Sergei Vladimirovich
  • Baranova Anna Viacheslavovna
  • Pokrovskii Vadim Sergeevich
  • Okhrimenko Ivan Stanislavovich
  • Manukhov Ilia Vladimirovich
RU2816486C2
METHOD OF REALIZATION OF SELECTIVE METHIONINE CELL STARVATION IN MAMMAL BODY, POLYNUCLEOTIDE, CATALYTICALLY ACTIVE POLYPEPTIDE OF RECOMBINANT METHYLTHIOADENOSINE PHOSPHORYLASE 1994
  • Nobori Tsutomu
  • Kason Dennis A.
RU2153885C2
COMPOSITION FOR INDUCTION OF SPECIFIC IMMUNOLOGICAL TOLERANCE 2010
  • Godfrin, Yann
  • Banz, Alice
RU2782223C2
METHOD FOR INCLUDING BIOLOGICALLY ACTIVE COMPONENTS IN ERYTHROCYTES BY METHOD OF FLOW HYPOOSMOTIC DIALYSIS 2021
  • Ataullakhanov Fazoil Inoyatovich
  • Zejnalov Azer Mamedovich
  • Sinauridze Elena Ivanovna
  • Koleva Larisa
RU2791817C1

RU 2 733 389 C2

Authors

Agera Karin

Berle Villi

Ge Faben

Godfren Yan

Dates

2020-10-01Published

2017-01-02Filed